Ocutrx Technologies, a leader in augmented reality (AR) and 3D visualisation technology for medical, enterprise, and gaming applications, has announced the addition of renowned neurosurgeon Dr. Robert Louis, MD, FAANS, FCNS to its Scientific Advisory Board.
Dr. Louis, Director of the Skull Base and Pituitary Tumor Program at Hoag Memorial Hospital Presbyterian in Newport Beach, Calif., is internationally recognised for pioneering minimally invasive and endoscopic neurosurgical procedures. He has long championed the use of emerging technologies—including intraoperative AR/VR imaging—to push the boundaries of what’s possible in brain and spine surgery.
His appointment marks a strategic step for Ocutrx as it extends its flagship DigiLoupes technology beyond orthopedic and spinal applications into complex neurosurgery. The company says Dr. Louis’s expertise will help shape DigiLoupes for delicate procedures such as brain tumour resection, treatment of spinal disorders, and management of neurological conditions like epilepsy and hydrocephalus.
“Dr. Louis is a change-maker in surgical science and a true visionary in applying technology to elevate patient care,” said Michael Freeman, CEO/CTO and Founder of Ocutrx. “His leadership will be invaluable as we develop next-generation visualisation tools that deliver unprecedented clarity, precision, and efficiency for neurosurgeons.”
Dr. Louis has published extensively and lectures worldwide on advanced neurosurgical techniques, AR/VR integration, and the future of digital surgery. He is deeply committed to training the next generation of surgeons and reimagining the OR of tomorrow.
“Ocutrx’s bold vision aligns perfectly with my passion for innovation in the operating room,” said Dr. Louis. “DigiLoupes is more than an upgrade—it’s a paradigm shift for real-time visualisation. Together, we have an opportunity to redefine how surgeons see, decide, and operate in some of the most delicate and high-stakes procedures.”
This collaboration underscores Ocutrx’s mission to pioneer surgical breakthroughs that restore surgeons’ vision in every sense—enhancing what they see, how they work, and the outcomes they deliver.